Related Experiment Video
Updated: Jun 15, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation
Cedric Delhaye1, Gabriel Maluenda, Kohei Wakabayashi
1Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, Washington, District of Columbia.
Insights
High preprocedural C-reactive protein (CRP) levels predict a higher risk of death and myocardial infarction after drug-eluting stent (DES) implantation at two years. This association was not observed acutely, suggesting CRP indicates broader cardiovascular risk.
Area of Science:
- Cardiology
- Biomarkers
- Interventional Cardiology
Background:
- C-reactive protein (CRP) elevation is linked to adverse cardiovascular outcomes post-stenting.
- Previous data suggest preprocedural CRP may predict events after drug-eluting stent (DES) implantation.
Purpose of the Study:
- To investigate the association between preprocedural CRP levels and cardiovascular events following DES implantation.
- To determine if CRP predicts acute versus long-term adverse outcomes post-DES.
Main Methods:
- Analysis of 936 patients undergoing DES implantation with preprocedural CRP measurements.
- Patients stratified into tertiles based on CRP levels (<1.31, 1.31-3.76, >3.76 mg/L).
- Primary endpoint: composite of death and Q-wave myocardial infarction (QWMI) at 2 years; secondary endpoint: target vessel revascularization.
Main Results:
- No significant difference in death/QWMI among CRP tertiles acutely or at 1 year.
- At 2 years, death/QWMI occurred in 2.9% (lowest tertile), 5.2% (middle), and 8.8% (highest tertile) (p=0.006).
- High CRP (upper tertile) was an independent predictor of death/QWMI at 2 years (HR 2.5; p=0.006). Target vessel revascularization rates were similar across groups.
Conclusions:
- Elevated preprocedural CRP is associated with increased long-term risk of death and QWMI after DES implantation.
- CRP does not appear to predict acute post-DES complications or target vessel revascularization.
- High CRP may serve as a marker of overall cardiovascular risk rather than a specific predictor of post-DES events.
Abstract:
C-reactive protein (CRP) elevation is associated with an adverse cardiovascular prognosis after bare metal stent implantation. Data have suggested a similar association between preprocedural CRP and adverse events after drug-eluting stent (DES) implantation. The present study was designed to address whether such a relation exists after DES placement. After excluding patients presenting with an acute coronary syndrome with troponin I elevation, we analyzed the data from 936 consecutive patients who had undergone DES implantation from 2003 to 2007 and had a preprocedural CRP measurement. The patients were divided into 3 groups according to the preprocedural CRP level (<1.31, 1.31-3.76, and >3.76 mg/L). The primary end point was the composite of death and Q-wave myocardial infarction (QWMI) at 2 years of follow-up. Target vessel revascularization was also assessed. The rate of death/QWMI was not significantly different statistically among the CRP tertiles during the in-hospital period (0.6% vs 0.0% vs 0.6%, p = 0.5) or at 1 year of follow-up (1.9% vs 2.9% vs 4.5%, p = 0.2). At 2 years, death/QWMI had occurred in 2.9% of patients in the lowest, 5.2% in the middle, and 8.8% in the highest tertile (p = 0.006). The incidence of target vessel revascularization was similar in the 3 groups at 2 years of follow-up (13.2% vs 14.9% vs 16.9%, p = 0.5). On multivariate analysis, the upper tertile of CRP was an independent predictor of death/QWMI at 2 years (hazard ratio 2.5, 95% confidence interval 1.1 to 5.4, tertile 3 vs tertile 1, p = 0.006). In conclusion, high preprocedural CRP levels are associated with an increased risk of death and QWMI after DES implantation at long-term follow-up but not acutely. The CRP levels were not related to target vessel revascularization. Thus, an elevated CRP level in this population appears to be more of a marker of global cardiovascular risk than a predictor of post-DES-related complications.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization I: Pre-Procedure Overview
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
